Medbroker ApS: Financial statements 2013
CVR: 31892236
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Medbroker ApS (CVR 31892236) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 4,525 and a net result of DKK -49,641 compared with DKK -1,544,478 the year before. Equity in the 2013 report amounted to DKK 121,930. The solvency ratio was 82%.
- Gross Profit
- DKK 4,525
- Profit/Loss
- DKK -49,641
- Equity
- DKK 121,930
- Total Assets
- DKK 148,690
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 5 t. | -50 t. | 122 t. | - |
| 2012 | - | -33 t. | -1.5 mio. | 172 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
Medbroker ApS has published its annual report for 2012. Gross profit came to DKK -33,294, and the net result was DKK -1,544,478.
About Medbroker ApS
Medbroker ApS is a Danish company of the type Anpartsselskab based in Gadstrup, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ORIGO BIOTECH ApS. The management consists of Henrik Carlheim Dørge. The board consists of Henrik Carlheim Dørge (chair). The company is owned by MEDBROKER INVEST ApS. The company has 3 employees (2023). In 2025, the company reported a gross profit of DKK -6,226 and a net result of DKK -78,938 compared with DKK -406,760 the year before. Equity in the 2025 report amounted to DKK 34,714.